Pages that link to "Item:Q5082671"
From MaRDI portal
The following pages link to A new design of the continual reassessment method (Q5082671):
Displaying 10 items.
- Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer (Q70258) (← links)
- A note on continual reassessment method (Q274178) (← links)
- Theoretical study of the continual reassessment method (Q2492919) (← links)
- A Bayesian adaptive dose-finding algorithm for balancing individual- and population-level ethics in Phase I clinical trials (Q2958397) (← links)
- Incorporating Individual and Collective Ethics into Phase I Cancer Trial Designs (Q3013989) (← links)
- Characterization of the likelihood continual reassessment method (Q3191468) (← links)
- Miscellanea. A stopping rule for the continual reassessment method (Q4216701) (← links)
- TWO-SAMPLE CONTINUAL REASSESSMENT METHOD (Q4244513) (← links)
- A continual reassessment method without undue risk of toxicity (Q6171847) (← links)
- A novel doubling-tripling-threshold accepting hybrid algorithm for constructing asymmetric space-filling designs (Q6548537) (← links)